Lineage Cell Therapeutics Inc (AMEX:LCTX) price on Thursday, June 12, rose 0.29% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $0.70.
A look at the stock’s price movement, the close in the last trading session was $0.70. Turning to its 52-week performance, $1.15 and $0.37 were the 52-week high and 52-week low respectively. Overall, LCTX moved 49.47% over the past month.
Lineage Cell Therapeutics Inc’s market cap currently stands at around $160.42 million, with investors looking forward to this quarter’s earnings report slated for in July.
Analysts have a consensus estimate of 1.47M for the company’s revenue for the quarter, with a low and high estimate of 1.27M and 1.92M respectively. The average forecast suggests up to a 4.59% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 6.7M, representing a -29.48% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that LCTX is a 50% Buy. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.
LCTX’s current price about 11.36% and 34.82% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 63.65, while 7-day volatility ratio is 5.36% and 5.92% in the 30-day chart. Further, Lineage Cell Therapeutics Inc (LCTX) has a beta value of 1.53, and an average true range (ATR) of 0.05.
If we refocus on Lineage Cell Therapeutics Inc (AMEX:LCTX), historical trading data shows that trading volumes averaged 1.43 million over the past 3 months. The company’s latest data on shares outstanding shows there are 228.36 million shares.
The 0.44% of Lineage Cell Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 48.65% of the company’s shares. Current price change has pushed the stock 39.80% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the LCTX stock continues to rise going into the next quarter.
